Nutrition & DietPress Release

Keto diet cuts liver fat 67% in adults with prediabetes in a small controlled feeding trial

In 42 adults with obesity, prediabetes and fatty liver, keto cut liver fat far more than Mediterranean or low-fat diets at similar weight loss.

Sunday, November 22, 2026 0 views
Published in ScienceDaily Nutrition
Article visualization: Keto diet cuts liver fat 67% in adults with prediabetes in a small controlled feeding trial

Summary

Fatty liver and prediabetes are common, age-related metabolic problems, and this trial asked whether diet composition matters beyond weight loss. Researchers at Washington University randomly assigned 42 adults with obesity, prediabetes and fatty liver disease to a ketogenic, Mediterranean or low-fat plant-focused diet. All meals were supplied, with weekly dietitian visits. After about four to five months, all three groups lost similar amounts of weight, yet the keto group's liver fat fell by an average of 67%, more than the other diets. About half of keto participants no longer met prediabetes criteria. The authors suggest cutting carbohydrate may have metabolic effects beyond weight loss in people with high liver fat. The trial is small, short, and used surrogate markers rather than clinical outcomes. The excerpt does not report long-term results or harms such as changes in LDL cholesterol, which matters because keto diets can be high in saturated fat.

0:00--:--

Detailed Summary

Fatty liver disease and prediabetes tend to accumulate with age and raise the risk of type 2 diabetes and cardiovascular disease. Doctors usually recommend weight loss, but it has been unclear whether the macronutrient makeup of a diet adds benefit when weight loss is the same. This trial, published in Cell Metabolism, tested exactly that question.

Researchers led by Samuel Klein at Washington University School of Medicine in St. Louis enrolled 42 adults with obesity, prediabetes and fatty liver disease. Participants were randomly assigned to a ketogenic diet, a Mediterranean diet, or a low-fat diet emphasizing plant foods. The team provided all meals and held weekly dietitian consultations to ensure adherence. The diets differed sharply in carbohydrate content, with low-fat diets providing as much as 70% of calories from carbohydrate.

After roughly four to five months, weight loss was similar across the three groups. Even so, liver fat fell by an average of 67% with the ketogenic diet, which outperformed the other two diets. About half of the keto participants no longer met diagnostic criteria for prediabetes. Klein said that with high liver fat and prediabetes, reducing carbohydrate may have therapeutic metabolic effects beyond weight loss alone.

The practical implication is that, for people with fatty liver and prediabetes, carbohydrate restriction is a mechanism-supported option worth discussing with a physician, particularly when other diets have not improved liver fat. Because meals were provided, results show what the diets can do under ideal adherence.

Caveats matter. The study is small, short and measured surrogate markers such as liver fat and glycemic status, not liver disease progression, diabetes incidence or cardiovascular events. Keto diets can include substantial saturated fat, and the excerpt does not report effects on LDL cholesterol or other harms. Real-world adherence is harder than in a supplied-meal trial, and durability beyond five months is unknown. Check the full paper for comparative numbers, dropout rates and safety data.

Key Findings

  • Randomized trial of 42 adults with obesity, prediabetes and fatty liver compared keto, Mediterranean and low-fat diets for about 4-5 months.
  • Weight loss was similar across the three diets, so keto's liver advantage was not explained by weight loss alone.
  • Liver fat fell by an average of 67% on keto, more than on the other diets.
  • About half of keto participants no longer met prediabetes criteria; this is a surrogate marker, not a diabetes outcome.
  • Long-term effects, lipid changes and harms were not reported in the excerpt; saturated fat intake on keto is a flagged concern.

Methodology

This is a news summary of a randomized controlled feeding trial in Cell Metabolism, distributed by Cell Press via ScienceDaily. The trial enrolled 42 adults and supplied all meals with weekly dietitian support, which strengthens adherence control. Endpoints are surrogates (liver fat, prediabetes status); the excerpt is truncated and omits some design details.

Study Limitations

The sample is small and short-term, and meals were provided, so real-world results may be smaller. Clinical outcomes, durability, lipid effects, dropouts and harms are not reported in the excerpt. Verify exact comparisons between groups and safety data in the original Cell Metabolism paper.

Enjoyed this summary?

Get the latest longevity research delivered to your inbox every week.

Enter your email to subscribe: